Arrowstreet Capital’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
SSM
DRZID
Arrowstreet Capital's OGN Position: Q4 2024 in Review
Arrowstreet Capital sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 20,738 shares — an estimated $397K sold.
Arrowstreet Capital first reported a position in OGN in Q2 2021 and held it in 13 quarters. The position peaked at $37M in Q3 2021. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.
- Arrowstreet Capital reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
- Arrowstreet Capital sold 20,738 Organon & Co shares in Q4 2024, an estimated $397K.
- Arrowstreet Capital first reported a position in Organon & Co in Q2 2021 and held it in 13 quarters.
- Arrowstreet Capital's Organon & Co position peaked at $37M in Q3 2021.
- 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.
Based on Arrowstreet Capital's 13F filing for Q4 2024, filed 12 Feb 2025.